Skip to results
Modify your search
NARROW
1-20 of 20
Authors: Lindsey R. Baden
Journal Article
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials Get access
The Journal of Infectious Diseases, Volume 230, Issue 6, 15 December 2024, Pages 1384–1389, https://doi.org/10.1093/infdis/jiae400
Published: 03 September 2024
Journal Article
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages e279–e286, https://doi.org/10.1093/infdis/jiae067
Published: 13 February 2024
Journal Article
Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages e405–e415, https://doi.org/10.1093/infdis/jiad434
Published: 05 October 2023
Journal Article
EDITOR'S CHOICE
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
The Journal of Infectious Diseases, Volume 228, Issue 12, 15 December 2023, Pages 1662–1666, https://doi.org/10.1093/infdis/jiad323
Published: 10 August 2023
Journal Article
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study
The Journal of Infectious Diseases, Volume 227, Issue 8, 15 April 2023, Pages 939–950, https://doi.org/10.1093/infdis/jiac445
Published: 09 November 2022
Journal Article
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
The Journal of Infectious Diseases, Volume 226, Issue 10, 15 November 2022, Pages 1731–1742, https://doi.org/10.1093/infdis/jiac188
Published: 10 May 2022
Journal Article
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
The Journal of Infectious Diseases, Volume 218, Issue 4, 15 August 2018, Pages 633–644, https://doi.org/10.1093/infdis/jiy212
Published: 13 April 2018
Journal Article
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083
The Journal of Infectious Diseases, Volume 213, Issue 4, 15 February 2016, Pages 541–550, https://doi.org/10.1093/infdis/jiv496
Published: 15 October 2015
Journal Article
Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans Get access
The Journal of Infectious Diseases, Volume 211, Issue 4, 15 February 2015, Pages 518–528, https://doi.org/10.1093/infdis/jiu485
Published: 26 August 2014
Journal Article
First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002) Get access
The Journal of Infectious Diseases, Volume 210, Issue 7, 1 October 2014, Pages 1052–1061, https://doi.org/10.1093/infdis/jiu217
Published: 08 April 2014
Journal Article
Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles Get access
The Journal of Infectious Diseases, Volume 210, Issue 1, 1 July 2014, Pages 99–110, https://doi.org/10.1093/infdis/jiu003
Published: 07 January 2014
Journal Article
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery Get access
The Journal of Infectious Diseases, Volume 208, Issue 5, 1 September 2013, Pages 818–829, https://doi.org/10.1093/infdis/jit236
Published: 08 July 2013
Journal Article
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial Get access
The Journal of Infectious Diseases, Volume 207, Issue 12, 15 June 2013, Pages 1888–1897, https://doi.org/10.1093/infdis/jit105
Published: 12 March 2013
Journal Article
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001) Get access
The Journal of Infectious Diseases, Volume 207, Issue 2, 15 January 2013, Pages 240–247, https://doi.org/10.1093/infdis/jis670
Published: 02 November 2012
Journal Article
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001) Get access
The Journal of Infectious Diseases, Volume 207, Issue 2, 15 January 2013, Pages 248–256, https://doi.org/10.1093/infdis/jis671
Published: 02 November 2012
Journal Article
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects Get access
The Journal of Infectious Diseases, Volume 204, Issue 10, 15 November 2011, Pages 1541–1549, https://doi.org/10.1093/infdis/jir615
Published: 21 September 2011
Journal Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles Get access
The Journal of Infectious Diseases, Volume 203, Issue 5, 1 March 2011, Pages 610–619, https://doi.org/10.1093/infdis/jiq105
Published: 01 March 2011
Journal Article
Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax Get access
The Journal of Infectious Diseases, Volume 201, Issue 9, 1 May 2010, Pages 1353–1360, https://doi.org/10.1086/651560
Published: 01 May 2010
Journal Article
Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration Get access
The Journal of Infectious Diseases, Volume 201, Issue 9, 1 May 2010, Pages 1361–1370, https://doi.org/10.1086/651561
Published: 01 May 2010
Journal Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects Get access
The Journal of Infectious Diseases, Volume 192, Issue 7, 1 October 2005, Pages 1249–1259, https://doi.org/10.1086/432915
Published: 01 October 2005
